Correction: Peripheral endocannabinoids in major depressive disorder and alcohol use disorder: a systematic review.
作者信息
Fuentes J J, Mayans J, Guarro M, Canosa I, Mestre-Pintó J I, Fonseca F, Torrens M
机构信息
Mental Health Institute, Hospital del Mar, Barcelona, Spain.
Department of Psychiatry and Forensic Medicine, Universitat Autònoma de Barcelona (UAB), Cerdanyola del Vallés, Spain.
出版信息
BMC Psychiatry. 2024 Oct 10;24(1):673. doi: 10.1186/s12888-024-06132-0.
Abstract
摘要
相似文献
1
Correction: Peripheral endocannabinoids in major depressive disorder and alcohol use disorder: a systematic review.更正：重度抑郁症和酒精使用障碍中的外周内源性大麻素：一项系统评价。
BMC Psychiatry. 2024 Oct 10;24(1):673. doi: 10.1186/s12888-024-06132-0.
2
Peripheral endocannabinoids in major depressive disorder and alcohol use disorder: a systematic review.主要抑郁障碍和酒精使用障碍中的外周内源性大麻素：系统综述。
BMC Psychiatry. 2024 Aug 8;24(1):551. doi: 10.1186/s12888-024-05986-8.
3
Associations of 5HTTLPR polymorphism with major depressive disorder and alcohol dependence: A systematic review and meta-analysis.5HTTLPR基因多态性与重度抑郁症和酒精依赖的关联：一项系统评价和荟萃分析。
Aust N Z J Psychiatry. 2016 Sep;50(9):842-57. doi: 10.1177/0004867416637920. Epub 2016 Mar 15.
4
Depressive symptoms are negatively associated with hair N-arachidonoylethanolamine (anandamide) levels: A cross-lagged panel analysis of four annual assessment waves examining hair endocannabinoids and cortisol.抑郁症状与毛发 N-花生四烯酸乙醇胺（花生四烯酸酰胺）水平呈负相关：一项对毛发内源性大麻素和皮质醇进行的四个年度评估波交叉滞后面板分析。
Prog Neuropsychopharmacol Biol Psychiatry. 2023 Mar 8;121:110658. doi: 10.1016/j.pnpbp.2022.110658. Epub 2022 Oct 15.
5
Peripheral IGF-1 in bipolar disorder and major depressive disorder: a systematic review and meta-analysis.双相情感障碍和重度抑郁症中的外周胰岛素样生长因子-1：系统评价与荟萃分析
Ann Palliat Med. 2020 Nov;9(6):4044-4053. doi: 10.21037/apm-20-1967.
6
Dual pharmacological inhibitor of endocannabinoid degrading enzymes reduces depressive-like behavior in female rats.双重内源性大麻素降解酶的药理学抑制剂可减少雌性大鼠的抑郁样行为。
J Psychiatr Res. 2020 Jan;120:103-112. doi: 10.1016/j.jpsychires.2019.10.010. Epub 2019 Oct 11.
7
Inverse correlation between plasma 2-arachidonoylglycerol levels and subjective severity of depression.血浆 2-花生四烯酸甘油水平与抑郁主观严重程度呈负相关。
Hum Psychopharmacol. 2021 Jul;36(4):e2779. doi: 10.1002/hup.2779. Epub 2021 Feb 9.
8
Clinical Efficacy and Biological Regulations of ω-3 PUFA-Derived Endocannabinoids in Major Depressive Disorder.ω-3 多不饱和脂肪酸衍生的内源性大麻素在重度抑郁症中的临床疗效和生物学调节作用。
Psychother Psychosom. 2019;88(4):215-224. doi: 10.1159/000501158. Epub 2019 Jul 3.
9
Hair-based biomarkers in women with major depressive disorder: Glucocorticoids, endocannabinoids, -acylethanolamines, and testosterone.重度抑郁症女性的毛发生物标志物：糖皮质激素、内源性大麻素、酰基乙醇胺和睾酮。
Compr Psychoneuroendocrinol. 2021 Jun 21;7:100068. doi: 10.1016/j.cpnec.2021.100068. eCollection 2021 Aug.
10
Circulating inflammatory markers, cell-free mitochondrial DNA, cortisol, endocannabinoids, and -acylethanolamines in female depressed outpatients.女性抑郁门诊患者的循环炎症标志物、无细胞线粒体 DNA、皮质醇、内源性大麻素和 -酰基乙醇胺。
World J Biol Psychiatry. 2023 Jan;24(1):58-69. doi: 10.1080/15622975.2022.2070666. Epub 2022 May 9.
本文引用的文献
1
Peripheral endocannabinoids in major depressive disorder and alcohol use disorder: a systematic review.主要抑郁障碍和酒精使用障碍中的外周内源性大麻素：系统综述。
BMC Psychiatry. 2024 Aug 8;24(1):551. doi: 10.1186/s12888-024-05986-8.
Zotero 插件